About: Contribution of human CYP3A subfamily members to the 6-hydroxylation of chlorzoxazone

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Contribution of human CYP3A subfamily members to the 6-hydroxylation of chlorzoxazone Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 March 1997

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в березні 1997 (uk) im März 1997 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en marzu de 1997 (ast) scientific article published on 01 March 1997 (en)
publication date	wds:Q73319486-E8D4A802-F47E-4276-A72E-D40B2804737C
publication date	1997-03-01 00:00:00Z (xsd:dateTime)
author name string	wds:Q73319486-38E4ECDE-A61C-46D3-A25E-AFEBEA67D413 wds:Q73319486-4B29BB83-6836-4DAA-B7A3-482FD9279817 wds:Q73319486-C29C385C-6450-4401-AE62-3F7C71A36D08 wds:Q73319486-D17265F8-EB4B-4E1A-A658-56613C953F70
author name string	S D Hall D R Jones S A Wrighton J C Gorski
rdfs:label	Contribution of human CYP3A subfamily members to the 6-hydroxylation of chlorzoxazone (en) Contribution of human CYP3A subfamily members to the 6-hydroxylation of chlorzoxazone (nl)
skos:prefLabel	Contribution of human CYP3A subfamily members to the 6-hydroxylation of chlorzoxazone (en) Contribution of human CYP3A subfamily members to the 6-hydroxylation of chlorzoxazone (nl)
name	Contribution of human CYP3A subfamily members to the 6-hydroxylation of chlorzoxazone (en) Contribution of human CYP3A subfamily members to the 6-hydroxylation of chlorzoxazone (nl)
title	wds:Q73319486-0B661EC7-5459-4777-9C6F-6CB2906EAED2
title	Contribution of human CYP3A subfamily members to the 6-hydroxylation of chlorzoxazone (en)
page(s)	wds:Q73319486-CBAB42C1-FD36-4D08-B535-B7647B5933F1
page(s)	243-256
instance of	wds:Q73319486-38317F7E-BB7E-4A76-8298-A5770F95A529
instance of	scholarly article
PubMed ID	wds:Q73319486-0BCE57EA-98BD-43AA-BD31-21C26B8E8014
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/9141232
PubMed ID	9141232
published in	wds:Q73319486-95C64803-ACE8-4910-9128-04322160990C
published in	Xenobiotica
issue	wds:Q73319486-50684F36-BBA7-4477-982F-3568BE3D9D3C
volume	wds:Q73319486-6D35AA5E-466B-4EF5-91E1-9EC0196DD73F
issue	3
volume	27
number of pages	wds:Q73319486-C82E7F70-AD21-482E-8B2F-843B7CD295CF
number of pages	14 (xsd:decimal)
DOI	wds:Q73319486-53123EE5-5623-4318-848E-45286184A277
DOI	http://dx.doi.org/10.1080/004982597240578
DOI	10.1080/004982597240578
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q73319486
is cites work of	Activation of phenacetin O-deethylase activity by alpha-naphthoflavone in human liver microsomes. Cytochrome CYP2E1 phenotyping and genotyping in the evaluation of health risks from exposure to polluted environments. Development of a comprehensive panel of antibodies against the major xenobiotic metabolising forms of cytochrome P450 in humans Comparative effect of colchicine and colchiceine on cytotoxicity and CYP gene expression in primary human hepatocytes. Chlorzoxazone metabolism is increased in fasted Sprague-Dawley rats Differential selectivity of cytochrome P450 inhibitors against probe substrates in human and rat liver microsomes Biotransformation of alprazolam by members of the human cytochrome P4503A subfamily Effects of recombinant human growth hormone on the pharmacokinetics of intravenous chlorzoxazone in rats with acute renal failure induced by uranyl nitrate An interaction between the cytochrome P450 probe substrates chlorzoxazone (CYP2E1) and midazolam (CYP3A) Diabetes mellitus increases the in vivo activity of cytochrome P450 2E1 in humans Inhibition of chlorzoxazone metabolism, a clinical probe for CYP2E1, by a single ingestion of watercress Use of inhibitory monoclonal antibodies to assess the contribution of cytochromes P450 to human drug metabolism How useful is the "cocktail approach" for evaluating human hepatic drug metabolizing capacity using cytochrome P450 phenotyping probes in vivo? Wild-type CYP102A1 as a biocatalyst: turnover of drugs usually metabolised by human liver enzymes Sucralose, a synthetic organochlorine sweetener: overview of biological issues Acetaminophen hepatotoxicity precipitated by short-term treatment of rats with ethanol and isopentanol: protection by triacetyloleandomycin Characterization of P-glycoprotein mediated transport of K02, a novel vinylsulfone peptidomimetic cysteine protease inhibitor, across MDR1-MDCK and Caco-2 cell monolayers Inhibition of CYP2E1 by chlormethiazole as measured by chlorzoxazone pharmacokinetics in patients with alcoholism and in healthy volunteers. Response: Similar effect of quercetin on CYP2E1 and CYP2C9 activities in humans? Phenotype distribution and gender-related differences of CYP2E1 activity in a Chinese population Characterization of Porcine Hepatic and Intestinal Drug Metabolizing CYP450: Comparison with Human Orthologues from A Quantitative, Activity and Selectivity Perspective Measurement of immunoreactive cytochrome P450 2E1 in human leucocytes Evaluation of rat hepatic 2E1 activity in function of age, sex and inducers: choice of an experimental model capable of testing the hepatotoxicity of low molecular weight compounds. Determination of chlorzoxazone and 6-hydroxychlorzoxazone in plasma by gas chromatography–mass spectrometry
is cites work of	wds:Q24542488-2AC13E92-9F72-4E4C-A3BB-1531BFD69A3F wds:Q52574048-659E2603-7425-4C5A-B711-2CE194EFBF9E wds:Q88657353-52EF8A6F-17A1-4A6D-8DB5-FE8842871A74 wds:Q44252918-80838876-7F7F-4434-BF08-29254832730A wds:Q44448165-572B3C02-B615-4B51-BAF0-8C9C37E0FC4F wds:Q61978849-1FBF0C51-1D86-4D3C-AA6E-1E4A0C3EFFAD wds:Q28142314-B6DA9B8F-B5BF-4FF1-AC2D-84F84E2508F4 wds:Q47261654-784E7DCD-E59D-4FBA-B561-0118EA4B99B8 wds:Q57550414-9A6A90D5-62E6-4A74-9707-67626B849577 wds:Q77484274-977B3C53-E17A-42B6-B481-E3555BF22DE3 wds:Q87151938-093C570D-C255-4B6E-B493-C47253020E39 wds:Q35149421-CB14559E-A89F-46E0-BAAF-13BBD7E18D44 wds:Q44000042-F4659F5F-E636-40A8-AD09-A7DD28897F37 wds:Q42284671-1C4A0CE9-0558-49BF-99E2-1BC4517E05EF wds:Q77322580-0FAEC474-9CD2-4DD5-89D8-165AB2CD1D60 wds:Q28365904-F40020E1-8AF5-484D-A3DA-76F14E37A7EA wds:Q47722066-56123B7A-1E44-4755-BFFA-184D05921D53 wds:Q93024486-5705DF9C-C696-40BD-8686-8FBCACC82F73 wds:Q34421651-5A6F9FBC-81F6-4B3E-8331-5ECCE2C0D497 wds:Q34657381-B0EDCB2E-A24C-44B1-AAC8-F029221B23AD wds:Q35825142-01C763C7-EA9F-4D7A-8B05-D6604149D4C7 wds:Q73375437-56B117CE-EC21-4D80-9659-48FF0D0F523A wds:Q34752002-3A3EE152-7CC7-4BC0-9ADA-56F3003AACC8 wds:Q93927471-DA41C38D-2C23-4C30-85D5-43DD2C09980E

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 180 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software